Qingdao Dingxing Qiguang Medical Industry Investment Fund Partnership (Limited Partnership), managed by Guojin Dingxing Investment Co., Ltd. entered into a share transfer agreement to acquire a 5.0025% stake in Xiamen Amoytop Biotech Co., Ltd. (SHSE : 688278) from Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) for approximately CNY 460 million on January 5, 2022. The consideration comprises of 20% 0f total consideration CNY 92 million to be paid within three working days from the effective date of the share transfer agreement and remaining transfer price CNY 368 million to be paid at closing. The CNY 22.608 is the per share price. Prior to transaction, Qingdao Dingxing held no stake in Xiamen Amoytop and Tonghua holds 27.40% stake in it. The transaction was approved at the 23rd meeting of the tenth board of directors of the Tonghua.

Qingdao Dingxing Qiguang Medical Industry Investment Fund Partnership (Limited Partnership), managed by Guojin Dingxing Investment Co., Ltd. completed the acquisition of 5.0025% stake in Xiamen Amoytop Biotech Co., Ltd. (SHSE : 688278) from Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) on January 27, 2022.